Stemtech Drops Eevia Health Takeover Plan, Seeks Nordic SME Listing for Viago Merger
Stemtech Corporation said in a Form 8-K that it has terminated its non-binding letter of intent for a proposed reverse takeover of Eevia Health Plc. The company said that after further due diligence it determined Eevia Health could not meet the deadlines needed to complete the transaction.
Stemtech and Seacret Direct, LLC, doing business as Viago, said they remain committed to their previously announced agreement to merge. The companies are now negotiating to merge into a company listed on Nordic SME Sweden, part of the Nordic Growth Market, although no definitive agreement has been signed.
The proposed transaction would require an exemption from the Swedish Securities Council from the obligation to make a bid, compliance with other regulatory requirements and the signing of definitive agreements.
More StemTech news
Stemtech CFO James Cardwell Resigns; Shrilakshmi Vadlapatla Named CFO
Stemtech Corporation said in a Form 8-K that James Cardwell resigned as chief financial officer on April 11, 2025, and that its board appointed Shrilakshmi Vadlapatla as CFO at...
Stemtech Signs Merger Agreement With Seacret Direct, Now VIAGO
NAPLES, Florida -- December 4, 2024 Stemtech Corporation has signed an agreement to complete its previously announced merger with Seacret Direct, which now operates as VIAGO....
Stemtech Names John Meyer President and Chief Operating Officer
Stemtech Corporation appointed John W. Meyer president and chief operating officer, and said he would also sit on the board. Meyer joined the company in 2006 and had already been...
StemTech Completes Reverse Merger and Becomes the Public Operating Company
Globe Net Wireless Corp. reported that on August 19, 2021 it closed a merger agreement with privately held Stemtech Corporation. The public company acquired all of the Stemtech...